脑卒中测量 pPrognostic测试的分析-死亡率 nomogram 预测缺血性脑卒中后的长期死亡率
Tae Jung Kim1,2, Ji Sung Lee3, Mi Sun Oh4
1Department of Neurology, Seoul National University Hospital, Seoul, Korea.
概括
这项研究开发了Stroke Measures Analysis of pRognostic Testing-Mortality (SMART-M) 工具,用于预测缺血性中风患者的长期死亡率. SMART-M 方法表现良好,有助于预后和治疗决策.
科学领域:
- 神经学 神经学
- 心血管医学 心血管医学
- 公共卫生 公共卫生
背景情况:
- 准确预测长期死亡率对于管理缺血性中风患者至关重要.
- 预后和治疗决策依赖于了解患者的结果.
- 开发可靠的预测方法对于个性化护理至关重要.
研究的目的:
- 开发和验证一种方法来预测缺血性中风后的1年和5年死亡率.
- 确定与长期死亡率相关的关键临床变量.
- 创建一个用户友好的预测工具,用于临床应用.
主要方法:
- 利用行政索赔和急性缺血性中风患者中风注册数据的链接数据集.
- 使用考克斯回归分析确定与长期死亡相关的临床变量.
- 构建了一个基于名ogram的预测系统,命名为SMART-M,并使用Harrell的C指数评估其性能.
主要成果:
- 包括42,207名缺血性中风患者 (平均年龄66.6岁,59.2%男性).
- 确定了许多死亡率预测因素,包括年龄,中风严重程度,并发症和治疗细节.
- 在SMART-M nomogram实现了高预测准确度,C统计为0.806 (培训) 和0.803 (验证).
结论:
- 开发的SMART-M方法在预测缺血性中风患者的长期死亡率方面表现强.
- 这个工具可以增强对临床医生和家庭患者预后的理解.
- SMART-M促进了有关治疗和护理管理的知情决策.
相关概念视频
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Comparing the Survival Analysis of Two or More Groups
164
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
164
Actuarial Approach
69
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
69
Kaplan-Meier Approach
115
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
115
Assumptions of Survival Analysis
111
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
111


